Virtual Link:

OBJECTIVES: Upon completion of this activity, the participant should be able to: 

• Identify patients with hypertrophic cardiomyopathy
• Discuss the follow up recommended for patients with hypertrophic cardiomyopathy
• Review current and newer treatment strategies for hypertrophic cardiomyopathy

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

ABIM MOC PART 2:  Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Faculty Disclosure: Dr. David Rawitscher is a consultant and speaker for Zoll Medical and a speaker for Bristol-Myers Squibb.

Planner(s) Disclosures: The planners (Slade Hodges and Hillary Prince) do not have a relevant financial interest or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

All relevant financial relationships have been mitigated.

For special needs assistance please contact: Hillary Prince